Drug intelligence / Profile preview

BioVisc Ortho Single

Development stage
Unknown
Lead developer
Biotech Healthcare
Modality
Implantable Hydrogels → Hydrogel Systems → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems
Administration
Intraarticular
01

Overview

BioVisc Ortho Single is an intra-articular viscosupplement developed by Biotech Vision Care for the treatment of pain associated with osteoarthritis of the knee. It consists of a sterile, pyrogen-free, non-animal origin, highly purified, cross-linked sodium hyaluronate solution. As a single-injection therapy, it is designed to supplement the synovial fluid, restoring its viscoelastic properties, which are typically diminished in osteoarthritic joints. The mechanism of action is primarily mechanical, providing lubrication and shock absorption to reduce friction and mechanical stress within the joint, thereby alleviating pain and improving joint mobility. Additionally, it may stimulate the endogenous production of hyaluronic acid by synovial cells.

Brand names
BioVisc Ortho Single
Other names
sodium hyaluronate injection

Beyond the preview

Go deeper on BioVisc Ortho Single.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on BioVisc Ortho Single.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call